Phibro Animal Health (PAHC) FCF Payout Ratio Growth (1y) (2015 - 2026)
Phibro Animal Health (PAHC) FCF Payout Ratio Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -14.68% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -49.97% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -49.30% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Phibro Animal Health | 1.44 Bn | 1.36 Bn | 125.68 Mn | 3,880.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.35% |
| Dec 31, 2025 | 12.78% |
| Sep 30, 2025 | -66.93% |
| Jun 30, 2025 | 89.01% |
| Mar 31, 2025 | -95.26% |
| Dec 31, 2024 | -380.47% |
| Sep 30, 2024 | 426.75% |
| Jun 30, 2024 | -39.14% |
| Mar 31, 2024 | 2,227.11% |
| Dec 31, 2023 | 63.19% |
| Sep 30, 2023 | 311.61% |
| Jun 30, 2023 | 154.36% |
| Mar 31, 2023 | 89.11% |
| Dec 31, 2022 | -42.78% |
| Sep 30, 2022 | 89.29% |
| Jun 30, 2022 | -1.59% |
| Mar 31, 2022 | -46.74% |
| Dec 31, 2021 | 119.18% |
| Sep 30, 2021 | -141.20% |
| Jun 30, 2021 | 223.24% |